Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

LSP BioVentures

Investor type Venture Capital


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 21
Average round size
The average size of a deal this fund participated in
Portfolio companies 20
Rounds per year 1.31
Lead investments 7
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 9
Key employees 10
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical

LSP BioVentures is the famous VC, which was founded in 2006. The company was established in North America in United States. The main department of described VC is located in the Cambridge.

We also calculated 10 valuable employees in our database.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Lumeon, Nouscom, Rainier Therapeutics. We can highlight the next thriving fund investment areas, such as Therapeutics, Medical. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.

Opposing the other organizations, this LSP BioVentures works on 21 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 44 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the LSP BioVentures, startups are often financed by Life Sciences Partners, VI Partners AG, Prolog Ventures. The meaningful sponsors for the fund in investment in the same round are VI Partners AG, Seventure Partners, PMV. In the next rounds fund is usually obtained by Life Sciences Partners, Neomed Management, Ysios Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of LSP BioVentures:
Typical Co-investors
LSP BioVentures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after LSP BioVentures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Ai Hexin Touzi China, Liaoning, Shenyang
Beijing Huadian Shidai Technology Development Beijing, Beijing, China
Beijing Zhiyun Asset Management Beijing, Beijing Shi, China
Blue Pool Capital China, Hong Kong, Hong Kong Island
China Reinsurance Group Beijing, Beijing, China
Hangzhou Yongyuan China, Hangzhou, Zhejiang
RoseRock Bryan, Texas, United States
The MasterCard Foundation Canada, Ontario, Toronto
Tibet Jiuzheng Capital Investment China, Shanxi, Xizhang
Tibet Kexin Venture Investment Partnership (L.P.) Chengguan District, China, Lhasa

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Life Science
$83M09 Sep 2021 California, United States

Muna Therapeutics

$73M09 Jul 2021 Copenhagen, Hovedstaden, Denmark

Innovative Molecules

Health Care
$23M09 Jun 2021 Munich, Bayern, Germany

Life Science
$188M14 Jan 2021 North Holland


Health Care
$30M11 Aug 2020 London, England, United Kingdom


$33M18 Jun 2019 Liège, Liège, Belgium


Health Care
$28M04 Dec 2018 London, England, United Kingdom

Aelin Therapeutics

Health Care
$31M11 Dec 2017 Wisconsin, United States


Health Care
$49M06 Nov 2017 Basel, Basel-City, Switzerland


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent LSP BioVentures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: